x
|
QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
o
|
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE
ACT
|
Oklahoma
|
73-1479206
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
No.)
|
|
Page
|
PART
I - FINANCIAL INFORMATION
|
|
|
|
Item
1. Financial
Statements
|
3
|
Item
2. Management’s Discussion and
Analysis or Plan of Operation
|
13
|
Item
3. Controls and
Procedures
|
20
|
|
|
PART
II - OTHER INFORMATION
|
|
|
|
Item
1. Legal Proceedings
|
21
|
Item
2. Unregistered Sales of Equity
Securities and Use of Proceeds
|
21
|
Item
3. Defaults Upon Senior
Securities
|
21
|
Item
4. Submission of Matters to a Vote of
Security Holders
|
21
|
Item
5. Other Information
|
21
|
Item
6. Exhibits and Reports on Form
8-K
|
21
|
|
|
SIGNATURES
|
22
|
Balance
Sheet as of June 30, 2007 (Unaudited)
|
4
|
Statements
of Operations for the three and six months ended June 30, 2007 and
2006 and from inception (January 1, 2001) to June 30, 2007
(Unaudited)
|
5
|
|
|
Statements
of Cash Flows for the six months ended June 30, 2007 and 2006 and
from
inception (January 1, 2001) to June 30, 2007 (Unaudited)
|
6
|
|
|
Notes
to Financial Statements, June 30, 2007 (Unaudited)
|
7
|
June
30,
|
||||
Assets
|
2007
|
|||
Current
assets:
|
||||
Cash
|
$
|
227,951
|
||
Prepaid
expenses
|
22,609
|
|||
Total
current assets
|
250,560
|
|||
Property
and equipment, net
|
4,561
|
|||
Debt
issue costs, net
|
159,300
|
|||
Total
assets
|
$
|
414,421
|
||
Liabilities
and Shareholders' Deficiency
|
||||
Current
liabilities:
|
||||
Current
maturities of convertible debentures payable
|
$
|
855,000
|
||
Accounts
payable
|
555,529
|
|||
Note
payable - related party
|
192,500
|
|||
Accrued
interest on debentures
|
10,879
|
|||
Total
current liabilities
|
1,613,908
|
|||
Convertible
debentures payable, less current maturities
|
215,000
|
|||
Accrued
interest on debentures
|
4,202
|
|||
219,202
|
||||
Total
liabilities
|
1,833,110
|
|||
Shareholders'
deficiency:
|
||||
Common
stock; $.0002 par, 250,000,000 shares authorized; 110,350,959 shares
issued and outstanding
|
22,070
|
|||
Additional
paid-in capital
|
3,757,880
|
|||
Deficit
accumulated during development stage
|
(5,198,639
|
)
|
||
Total
shareholders' deficiency
|
(1,418,689
|
)
|
||
Total
liabilities and shareholders deficiency
|
$
|
414,421
|
Three
Months Ended
June
30, 2007
|
Three
Months Ended
June
30, 2006
|
Six
Months Ended
June
30, 2007
|
Six
Months Ended
June
30, 2006
|
Inception
to
June
30,
2007
|
||||||||||||
Income:
|
||||||||||||||||
Sales
|
$
|
-
|
$ |
-
|
$ |
-
|
$ |
-
|
$ |
-
|
||||||
Expenses:
|
||||||||||||||||
Research
and development
|
316,277
|
-
|
420,888
|
240,355
|
909,759
|
|||||||||||
General
and administrative
|
471,061
|
284,964
|
1,271,712
|
442,661
|
4,221,856
|
|||||||||||
Interest
|
23,462
|
2,277
|
36,506
|
7,929
|
67,024
|
|||||||||||
Total
expenses
|
810,800
|
287,241
|
1,729,106
|
690,945
|
5,198,639
|
|||||||||||
Net
loss
|
$
|
(810,800
|
)
|
$
|
(287,241
|
)
|
$
|
(1,729,106
|
)
|
$
|
(690,945
|
)
|
$
|
(5,198,639
|
)
|
|
Loss
per share:
|
||||||||||||||||
Basic
and diluted
|
$
|
(.008
|
)
|
$
|
(.003
|
)
|
$
|
(.017
|
)
|
$
|
(.008
|
)
|
||||
Weighted
average shares outstanding,
|
||||||||||||||||
Basic
and diluted
|
107,300,549
|
89,095,434
|
103,547,990
|
82,596,532
|
Six
Months Ended
June
30, 2007
|
Six
Months Ended
June
30, 2006
|
Inception
to
June
30,
2007
|
||||||||
Cash
Flows from Operating Activities
|
||||||||||
Net
loss
|
$
|
(1,729,106
|
)
|
$
|
(690,945
|
)
|
$
|
(5,198,639
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||
Options
and stock issued for services
|
631,000
|
102,988
|
1,273,323
|
|||||||
Asset
impairment
|
-
|
—
|
292,202
|
|||||||
Accrued
interest converted to stock
|
27,165
|
—
|
27,165
|
|||||||
Depreciation
|
563
|
—
|
915
|
|||||||
Amortization
of deferred debenture cost
|
23,802
|
—
|
23,802
|
|||||||
Change
in:
|
||||||||||
Prepaid
expenses and other assets
|
35,052
|
3,451
|
(69,544
|
)
|
||||||
Accounts
payable and accrued liabilities
|
167,025
|
(55,650
|
)
|
599,610
|
||||||
Net
cash used in operating activities
|
(844,499
|
)
|
(640,156
|
)
|
(3,051,166
|
)
|
||||
Cash
Flows from Investing Activities
|
||||||||||
Purchase
of office furniture and equipment
|
(314)
|
(1,882)
|
(5,476)
|
|||||||
Net
cash used in investing activities
|
(314)
|
(1,882)
|
(5,476)
|
|||||||
Cash
Flows from Financing Activities
|
||||||||||
Proceeds
from stock and warrant sales and exercise of warrants
|
124,000
|
532,723
|
1,598,250
|
|||||||
Proceed
from related party loan
|
192,500
|
—
|
192,500
|
|||||||
Increase in deferred debenture cost |
(136,167)
|
(136,167)
|
||||||||
Proceeds
from issuance of debentures
|
690,000
|
—
|
1,630,000
|
|||||||
Net
cash provided by financing activities
|
870,333
|
532,723
|
3,284,583
|
|||||||
Net
increase (decrease) in cash
|
25,520
|
(109,315
|
)
|
227,941
|
||||||
Cash,
beginning of period
|
202,431
|
147,371
|
10
|
|||||||
Cash,
end of period
|
$
|
227,951
|
$
|
38,056
|
$
|
227,951
|
||||
Supplemental
Disclosures
|
||||||||||
Non-Cash
Investing and Financing Activities
|
||||||||||
Conversion
of debentures to common stock
|
$
|
410,000
|
$
|
—
|
$
|
560,000
|
June
30, 2007
|
||||
Senior
Convertible Debentures:
|
||||
9.75%
Debenture due 2008
|
$
|
700,000
|
||
6.25%
Debentures due 2009
|
115,000
|
|||
4.75%
Debentures due 2011
|
100,000
|
|||
915,000
|
||||
8.00%
Unsecured Debentures due 2007
|
155,000
|
|||
Total
Debentures
|
1,070,000
|
|||
Less
- Current Maturities
|
(855,000
|
)
|
||
Long-term
Debentures
|
$
|
215,000
|
1. |
The
Registration Statement for the November 3, 2006 6 ¼ % debentures with
Golden Gate and the November 3, 2006 $100,000 debenture with Golden
Gate
is not filed within 3 days of the closing of this transaction; and
is not
effective by September 14, 2007.
|
2. |
The
common stock of the Company trades at a price per share of $0.21
or lower,
regardless of whether the trading price subsequently is higher than
$0.21
per share; or
|
3. |
Any
scheduled monthly payment of interest under the debenture is more
than one
day late.
|
(a) |
Between
January 1, 2007 and March 31, 2007, the option to purchase 2.5 million
shares of company stock, which shares were issued in the first quarter
of
2007. (see Note 3); and
|
(b) |
Between
June 1, 2007 and October 31, 2007, the option to purchase 2.5 million
shares of Company stock
|
(a) |
Swept
Volume Display Technology
|
(b) |
An
alternate approach to the volumetric display in which certain media,
such
as nano-particles in a transparent or semi-transparent medium to
produce
an innovative volumetric “projection screen”. This, in addition to
existing and rapidly evolving image projection technologies, such
as DLP
technology from Texas Instruments, are being innovatively incorporated
to
produce full-color, full-motion 3D visualization, and in harmony
with
3DIcon’s vision for product
development.
|
Description
of Patent Application as filed
|
Provisional
US Patent File No.
|
Description
of Utility Patent
Application
Filing
|
Utility
Patent File No.
|
Date
of Filing
|
Swept
Volume Display
|
|
Swept
Volume Display
|
US
11/528.306
|
9/27/2006
|
Colorful
Translation Light Surface 3D Display
|
US
60/794,901
|
Light
Surface Display for Rendering Three-Dimensional Image
(Combined)
|
US
11/789.767
|
4/25/2007
|
Colorful
Translation 3D Volumetric Display
|
US
60/796,249
|
|||
3D
Light Surface Display
|
US
60/854,557
|
|||
Volumetric
Liquid Crystal Display
|
US
60/794,903
|
Volumetric
Liquid Crystal Display for Rendering Three-Dimensional Image
(Combined)
|
US
11/789,674
|
4/25/2007
|
Volumetric
Liquid Crystal Display
|
US
60/877,404
|
|||
Computer
System Interaction with DMD
|
US
60/898,008
|
Utility
Patent Application to be filed
|
|
1/29/2007
|
|
·
|
Provide
2nd
proof-of-concept prototype with LEDs by mid 2007;
|
|
·
|
Investigate
alternate image pane technologies (3 Color LED; OLED) by September
1;
|
|
·
|
If
3-color LED prototype is not satisfactory, develop new prototype
by
December 1
|
|
·
|
Develop
single-color prototype and solve alignment issues;
|
|
·
|
Develop
Software;
|
|
·
|
Develop
multicolor prototype (materials dependent);
|
|
·
|
Provide
prototype demonstration in the summer of
2007.
|
|
·
|
Identify
and synthesize further optical up conversion nano-sized
materials;
|
|
·
|
Synthesize
and optimize aero gels or near transparent projection
materials;
|
|
·
|
Embed
light-emitting nano-particles;
|
|
·
|
Test
2-photon materials;
|
|
·
|
Investigate
encapsulating materials;
|
|
·
|
Synthesize
quantum dots, tune, and characterize quantum
dots.
|
|
·
|
Image
capture survey;
|
|
·
|
Develop
conversion/translation software;
|
|
·
|
Continue
with investigation of integral imaging
techniques.
|
|
·
|
Research
and development expenses pursuant to our Sponsored Research Agreement
with
the University of Oklahoma. This includes development of an initial
demonstrable prototype and a second prototype with Phase II technology;
|
·
|
Operating
expenses: salaries; insurance; investor related expenses; rent; travel
etc.
|
|
|
·
|
Hiring
executive officers for operations and
finance
|
|
·
|
Professional
fees for accounting and audit; legal services for securities and
financing; patent research and protection;
|
Exhibit
Number
|
Description
|
31.1
|
Certification
by Chief Executive Officer, required by Rule 13a-14(a) or Rule 15d-14(a)
of the Exchange Act.
|
31.2
|
Certification
by Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a)
of the Exchange Act.
|
32.1
|
Certification
by Chief Executive Officer, required by Rule 13a-14(b) or Rule 15d-14(b)
of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of
the
United States Code.
|
32.2
|
Certification
by and Chief Financial Officer, required by Rule 13a-14(b) or Rule
15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title
18
of the United States Code.
|
3DICON CORPORATION | ||
|
|
|
Date: August 17, 2007 | By: | /s/ Martin Keating |
Martin Keating |
||
Chief
Executive Officer and Acting Chief Financial Officer
(Principal
Executive and Financial
Officer)
|